Suche

Press release #Working at Bosch
share

Covid-19 vaccination campaign: Bosch plans extensive vaccination program for associates

Company doctors ready and waiting

  • Member of the Bosch board of management Filiz Albrecht: “We want to contribute to the vaccination drive in Germany. We care deeply about the health of our associates and the general public.”
  • Vaccination center at the Renningen research campus has capacity for up to 1,400 vaccinations daily; Bosch can vaccinate up to 6,000 people per day in Germany – program also planned for associates’ relatives.
  • Medical team comprises some 200 associates in Germany, including 50 company doctors; considerable experience with vaccinations.
  • Bosch also assisting local vaccination campaigns in other countries.
Trix Boehne

Trix Boehne

X

Renningen / Stuttgart – Bosch, the supplier of technology and services, plans to open vaccination centers at a number of its locations in Germany. It aims to offer a Covid-19 vaccination to its 130,000 associates in Germany, assuming corresponding vaccine availability. “We want to contribute to the vaccination drive in Germany. The infrastructure is in place and our company doctors are ready and waiting. They will start the vaccinations as soon as we get the green light,” says Filiz Albrecht, member of the Bosch board of management and director of industrial relations, on the plans of the company. “We care deeply about the health of our associates and of the general public, as we are demonstrating with this comprehensive vaccination commitment.” On the Renningen research campus site alone, Bosch plans to offer up to 1,400 vaccinations a day in a larger center for employees in the greater Stuttgart area.

Associates will also be able to get vaccinated by local vaccination centers and company medical staff at over 50 other locations. A concept for mobile vaccination teams has been developed to support smaller locations. In addition, the company plans to extend the offer to relatives if there is sufficient availability of the vaccine and if the authorities give the go-ahead for this. In total, Bosch can vaccinate up to 6,000 people a day in Germany. Vaccinations will be voluntary, subject to medical advice, and in line with prioritization rules. Final preparations are underway, including training for the medical team and discussions with authorities on vaccine procurement. For its vaccination campaign, Bosch is drawing on the competence of its company doctors as well as other internal expertise. The Bosch Service Solutions division is running the software-based vaccination registration system. The vaccination cabins at the Renningen vaccination center were built in a short space of time using aluminum sections from industrial technology company Bosch Rexroth and can be customized and expanded according to requirements.

High levels of qualification and experience among Bosch company doctors

The Bosch medical team comprises some 200 associates, including 50 company doctors. “Bosch company doctors are vastly experienced at administering vaccinations,” says Falko Papenfuß, head of the Bosch medical service. “For many years they have offered general vaccination advice, provided travel-related medical care, and been responsible for associates’ seasonal flu vaccinations.” In 2020, 18,000 associates in Germany received a flu vaccination. People outside of Bosch also benefit from the company doctors’ competence: Bosch medical experts have been assisting the nationwide vaccination campaign in Germany over the past few months, including at the vaccination center at the Robert Bosch Hospital in Stuttgart.

Protective measures remain in place, comprehensive test offer

The protective measures introduced at the beginning of the pandemic continue to apply at all locations and are being continuously updated based on the latest guidelines and medical findings. Bosch has been providing associates unable to work from home with regular Covid-19 antigen self-tests for a number of weeks now. Associates at German locations can take multiple self-tests per week, or even on a daily basis, depending on the local situation. Bosch is also deploying its own rapid PCR test using the Vivalytic analysis device, which was developed in-house, at more than 50 locations in Europe as part of its testing concept. Associates also continue to receive Bosch-produced face masks.

Worldwide commitment to vaccination campaign

Bosch also plans to offer vaccinations to its associates internationally, where possible. Associates at a number of international locations, including in China, France, India, Romania, Russia, Serbia, and the U.S., have already been able to receive vaccinations. As is standard practice in these countries, Bosch has been responsible for organizing vaccinations for its associates – mostly through external bodies or medical services. In some cases, Bosch has also offered organized trips to public vaccination centers for its associates in collaboration with local authorities. The company has opened a larger vaccination center together with the local government on the site of its plant in Cluj, Romania – another is operated by the Indian authorities at the plant in Adugodi (Bengaluru). Bosch employs more than 3,500 associates there.

About Bosch

The Bosch Group is a leading global supplier of technology and services. It employs roughly 429,000 associates worldwide (as of December 31, 2023). The company generated sales of 91.6 billion euros in 2023. Its operations are divided into four business sectors: Mobility, Industrial Technology, Consumer Goods, and Energy and Building Technology. With its business activities, the company aims to use technology to help shape universal trends such as automation, electrification, digitalization, connectivity, and an orientation to sustainability. In this context, Bosch’s broad diversification across regions and industries strengthens its innovativeness and robustness. Bosch uses its proven expertise in sensor technology, software, and services to offer customers cross-domain solutions from a single source. It also applies its expertise in connectivity and artificial intelligence in order to develop and manufacture user-friendly, sustainable products. With technology that is “Invented for life,” Bosch wants to help improve quality of life and conserve natural resources. The Bosch Group comprises Robert Bosch GmbH and its roughly 470 subsidiary and regional companies in over 60 countries. Including sales and service partners, Bosch’s global manufacturing, engineering, and sales network covers nearly every country in the world. Bosch’s innovative strength is key to the company’s further development. At 136 locations across the globe, Bosch employs some 90,000 associates in research and development, of which nearly 48,000 are software engineers.

The company was set up in Stuttgart in 1886 by Robert Bosch (1861–1942) as “Workshop for Precision Mechanics and Electrical Engineering.” The special ownership structure of Robert Bosch GmbH guarantees the entrepreneurial freedom of the Bosch Group, making it possible for the company to plan over the long term and to undertake significant upfront investments in the safeguarding of its future. Ninety-four percent of the share capital of Robert Bosch GmbH is held by Robert Bosch Stiftung GmbH, a charitable foundation. The remaining shares are held by Robert Bosch GmbH and by a corporation owned by the Bosch family. The majority of voting rights are held by Robert Bosch Industrietreuhand KG. It is entrusted with the task of safeguarding the company’s long-term existence and in particular its financial independence – in line with the mission handed down in the will of the company’s founder, Robert Bosch.

Additional information is available online at www.bosch.com, www.iot.bosch.com, www.bosch-press.com.

download